M&As

Novartis' drug delivery deal with Alteogen; More worker cuts at Cellares

Endpoints News 1h ago

Plus, news about Novonesis, Aspen, Fortrea and Northway. Alteogen and Novartis make a deal: The Swiss pharma is licensing Alteogen’s hyaluronidase enzyme, called ALT-B4, which is manufactured using a tech platform ...

Discussion

Sign in to join the discussion. Comments loading…